Sandakerveien 130 (map)
1st and 2nd floor
Digital technologies are often embraced as the solution to global challenges within health and development, but rampant commercialisation and weak regulation challenge the ideal of digital public goods capable of reducing inequalities.
Access to, and the affordability of, medicines is now attracting increased global attention. Some of this is the result of SDG 3 – ensuring healthy lives and promoting wellbeing for all at all ages – which includes a specific target (3.8): “Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all.”